Clinical significance of c-myc and p53 expression in head and neck squamous cell carcinomas
Authors:
- Suely NonogakiSNSuely Nonogaki
- Inês N NishimotoINInês N Nishimoto
- Luiz P KowalskiLuiz P Kowalski
- Roberto E.V MiguelRMRoberto E.V Miguel
- Ricardo R BrentaniRBRicardo R Brentani
- M.M BrentaniMBM.M Brentani
- 1 July 2004
- journal article
- research article
- Published by Elsevier in Cancer Detection Prevention
- Vol. 28 (3) , 178-186
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Targeted expression of c-Myc in the epidermis alters normal proliferation, differentiation and UV-B induced apoptosisOncogene, 1999
- MYC oncogenes and human neoplastic diseaseOncogene, 1999
- Reversible Activation of c-Myc in SkinMolecular Cell, 1999
- Co‐overexpression of p53 and c‐myc proteins linked with advanced stages of betel‐ and tobacco‐related oral squamous cell carcinomas from eastern IndiaEuropean Journal of Oral Sciences, 1998
- Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1.Genes & Development, 1994
- c-myc Oncoprotein expression in oral precancerous and early cancerous lesionsOral Oncology, 1993
- Head and Neck CancerNew England Journal of Medicine, 1993
- Analysis of gene amplification in head‐and‐neck squamous‐cell carcinomasInternational Journal of Cancer, 1991
- Expression of c‐erbB2 and c‐myc in squamous epithelia and squamous cell carcinomas of the head and neck and the lower female genital tractJournal of Oral Pathology & Medicine, 1990
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958